Single Escalating Dose Study Of HSK7653 In Healthy Subjects

Summary

To evaluate the safety, tolerability, pharmacokinetic (PK) and pharmacodynamic (PD) characteristics of single dose of HSK7653 tablets in healthy adult subjects, and to identify the metabolites of HSK7653 in healthy adult subjects

Timeline

Start

2018-05-08

Primary completion

2019-07-03

Completion

2019-07-03

Drugs

Indications